complicated intra abdominal

Related by string. Complicated intra abdominal * Complicated . COMPLICATED . Complicating : Village Idiot Complicating . Further complicating matters . Avril Lavigne Complicated / INTRA . Intra : intra venous . Signals Consistent Performance Intra . #.#/# intra day / abdominals . Abdominal . ABDOMINAL : severe abdominal pain . diarrhea abdominal cramps . abdominal strain * *

Related by context. All words. (Click for frequent words.) 83 infections cIAI 75 intravenous iclaprim 73 intra abdominal infections 71 cSSSI 71 cSSTI 70 nosocomial pneumonia 69 toenail onychomycosis 69 oropharyngeal candidiasis OPC 68 Complicated Skin 68 Kit CD# positive 68 Peginterferon alfa 2b 67 Application MAA 67 vapreotide acetate 66 invasive candidiasis 66 esophageal candidiasis 66 cIAI 65 sorafenib tablets 65 daptomycin 65 cutaneous T 65 refractory chronic lymphocytic 65 Clostridium difficile associated 65 treat chronic sinusitis 65 hypereosinophilic syndrome 65 DORIBAX 65 right sided endocarditis 65 lexidronam injection 65 methylnaltrexone bromide 64 ceftazidime 64 myelodysplastic myeloproliferative diseases 64 vinorelbine tartrate 64 superficial basal cell carcinoma 64 vaginal candidiasis 64 human C1 inhibitor 64 cUTI 64 itraconazole Sporanox 64 Lambert Eaton Myasthenic 64 systemic anaplastic large 63 Dementia Related Psychosis 63 documented candidiasis 63 docetaxel Taxotere ® 63 essential thrombocythemia ET 63 Crofelemer budesonide foam 63 infection sinusitis 63 Recombinant interferon alpha 63 injectable antibiotic 63 sorafenib Nexavar 63 cSSSIs 63 thetreatment 63 Topical Suspension 63 miconazole Lauriad ® 63 methicillin susceptible Staphylococcus aureus 63 alfa 2a 63 Escherichia coli Klebsiella pneumoniae 63 dasatinib Sprycel ® 63 sapropterin dihydrochloride 63 docetaxel Taxotere R 63 fibrosis IPF 63 drug resistant Streptococcus 63 mediastinitis 63 brivanib 62 Personalized Immunotherapy 62 Enterococcus faecium 62 Amgen Neulasta R 62 IIb clinical trial 62 targeted antifolate 62 hypervascular tumors 62 novel emulsion formulation 62 candidates Azedra TM 62 chronic eosinophilic leukemia 62 Phase IIb Trial 62 topically applied SEPA 62 Gamunex C 62 Vitrasert R 62 Telavancin 62 indinavir Crixivan 62 investigational antibiotic 62 myelofibrosis polycythemia vera 62 investigational oral hepatitis C 62 Fludara ® 62 Initiates Enrollment 62 Streptococcus pyogenes 62 Receives Orphan Drug Designation 62 Irinotecan 62 Tezampanel 62 Pafuramidine 62 Viread tenofovir disoproxil fumarate 62 Syndrome LEMS 62 diaper dermatitis complicated 62 COPEGUS R 62 Mylan Receives Approval 62 QUADRAMET R 62 voriconazole 62 MKC# MKC# PP 62 dasatinib Sprycel 62 Pivotal Study 62 SPL# Gel vaginal microbicide 62 Bilive R combined 62 Wafer polifeprosan 62 Opterone R 62 coronary stent merged 62 metastatic malignant 62 disease CDAD 62 non nucleoside inhibitor 62 reslizumab 62 acyclovir Lauriad R 62 nasal decolonization 62 bevacizumab Avastin R 62 including eniluracil ADH 61 Bendamustine 61 acetonide FA 61 endoluminal stent graft 61 JZP 61 Mg Usa 61 HepaGam B TM 61 Stanate R 61 ciprofloxacin hydrochloride 61 Kuvan R 61 induced macular edema 61 Shigatoxin producing E. coli 61 Afinitor everolimus 61 Camptosar ® 61 kidney urologic 61 Cloretazine ® 61 Lenocta TM 61 CYT# potent vascular disrupting 61 severe malignant osteopetrosis 61 TYGACIL 61 topical antifungal 61 Initiates Phase II 61 targeted radiotherapeutic 61 Pemetrexed 61 FACTIVE ® 61 diagnostic radiopharmaceutical 61 Bacteremia 61 DIFICID ™ 61 Sudhir Agrawal D.Phil 61 Alinia 61 Moraxella catarrhalis 61 PRN FDA Approves 61 PDX pralatrexate 61 refractory cutaneous T 61 Xcytrin R 61 inhalation powder 61 thalidomide Thalomid 61 FDA APPROVES 61 acute peripheral arterial 61 diarrhea fatigue asthenia 61 Evoltra ® 61 Achieves Primary Endpoint 61 dihydrochloride Tablets 61 HCl PEPCID ® famotidine 61 reduce serum phosphate 61 congenital ichthyosis 61 Daptomycin 61 non resectable metastatic 61 SPRYCEL ® 61 Severe Sepsis 61 investigational antiplatelet agent 61 FDA Accepts 61 cetuximab Erbitux R 61 intravesical infusion therapy 61 acute herpetic keratitis 61 lintuzumab SGN 61 Noxafil 61 REPRONEX R menotropins 61 IMiDs ® compound 61 tazobactam 61 hoFH 61 MIVI III 61 virus HCV protease inhibitor 61 investigational oral inhibitor 61 GTC recombinant form 61 Pivotal Phase III 61 dependent kinase inhibitor 60 abacavir sulfate lamivudine 60 broad spectrum cephalosporin 60 budesonide foam 60 MetroGel 60 arsenic trioxide injection 60 TO AVOID PREGNANCY WHILE 60 Pegloticase 60 PNP inhibitor 60 MKC# MT 60 Albuferon TM 60 IMiDs R 60 Kuvan TM sapropterin 60 LymphoStat B belimumab 60 R Saizen R 60 CYP#A# CYP#D# 60 liver resection surgeries 60 Orally administered 60 Cloretazine 60 oropharyngeal candidiasis 60 miconazole MBT 60 ® bortezomib 60 Anidulafungin 60 pan histone deacetylase 60 anti PlGF 60 hypertrichosis occurred 60 meropenem 60 LEUKINE 60 STELARA TM 60 phase III isavuconazole 60 rALLy clinical trial 60 MEK Inhibitor 60 Faropenem 60 diarrhea predominant irritable 60 accumulate preferentially 60 hemorrhagic cystitis 60 arthritis PsA 60 Adenoviral 60 penicillin resistant Streptococcus 60 Bayer HealthCare Onyx Pharmaceuticals 60 vitreoretinal disorders 60 humanized therapeutic 60 MRSAid TM 60 R lenalidomide 60 Dose Ranging Study 60 ABLYNX 60 dalbavancin 60 topical gel formulation 60 ELADUR TM 60 Liprotamase 60 Meets Primary Endpoint 60 Phase 2b Clinical Trial 60 nephropathic cystinosis 60 dihydrochloride 60 Nexavar ® 60 OvaRex ® MAb 60 Advanced Melanoma 60 Bosutinib 60 Loceryl ® 60 HFA MDI 60 MOVIPREP R 60 IN PATIENTS WITH 60 Aldara ® 60 stable angina pectoris 60 Prodarsan R 60 treating abdominal aortic 60 NS5b 60 lexidronam injection PROSTASCINT 60 Bazedoxifene 60 Alocrest 60 Atripla combines 60 Clindamycin 60 psoriasis Crohn disease 60 VISICOL R 60 monoclonal antibody IgG1 Mab 60 R sorafenib tablets 60 Enterobacter cloacae 60 catheter occlusion 60 systemic fungal infections 60 unresectable recurrent 60 Moxifloxacin 60 Zorbtive TM 60 AVASTIN 60 FOLOTYN ® 60 PEGylated Fab fragment 60 Vicinium TM 60 AAG geldanamycin analog 60 Metastatic Colorectal Cancer 60 Velcade bortezomib 60 Combination REOLYSIN R 60 antibiotic candidate Ramoplanin 60 ulcerative colitis Crohn disease 60 Refractory Hodgkin Lymphoma 60 ADP receptor antagonist 60 ketolide antibiotic 60 cell lymphoma CTCL 60 Genasense ® 60 posaconazole 60 Phase #b/#a clinical 60 Hsp# Inhibitor 60 By JAMAAL ABDUL 59 Demonstrates Sustained 59 rheumatoid arthritis psoriatic arthritis 59 INSPIRE Trial Phase III 59 Xyfid TM 59 Fluconazole 59 selective orally bioavailable 59 Ecallantide 59 hepatitis C HCV 59 BRIM2 59 markets COLAZAL 59 liposomal formulation 59 Augment TM 59 oxypurinol 59 Initiate Clinical Trial 59 5 fluorouracil leucovorin 59 Kristalose ® lactulose 59 Completes Patient Enrollment 59 HGS ETR1 mapatumumab 59 Dalbavancin 59 mesylate 59 Yondelis ® 59 Initiates Clinical Trial 59 Announces Tentative Approval 59 herpetic keratitis 59 Prolongs Survival 59 relapsed refractory multiple myeloma 59 Fast Track Status 59 2 methoxyestradiol 59 ALN HPN 59 samarium Sm 59 Myocet 59 Methylnaltrexone 59 Adjuvant Treatment 59 leukemia AML 59 prokinetic agent 59 Levoleucovorin 59 Pivotal Trial 59 Systemic Sclerosis 59 histone deacetylase HDAC inhibitor 59 irinotecan containing 59 terlipressin 59 pediatric Crohn disease 59 Proquin XR 59 developing Zerenex ferric 59 oral antifungal 59 SUPPRELIN R LA 59 proprietary radiolabeled monoclonal 59 sarcoma melanoma 59 Panzem R 59 Aztreonam 59 benign prostatic hypertrophy BPH 59 polycythemia vera essential thrombocythemia 59 metastatic neuroendocrine tumors 59 steroid refractory GvHD 59 immune globulin intravenous 59 oral anti arrhythmic 59 advanced metastatic renal 59 TEMODAL 59 nucleoside analog 59 PEGINTRON TM 59 delivers fluocinolone acetonide FA 59 Galderma SA 59 Phase IIb Clinical Trial 59 IMiDs ® 59 Solution XOPENEX HFA 59 fumarate 59 PI3K/Akt pathway inhibitor 59 Frozen Shoulder syndrome Adhesive 59 Metformin HCl 59 PROSTASCINT R 59 evaluating picoplatin 59 metformin XR 59 Linezolid 59 oral prodrug 59 Tigecycline 59 included exfoliative dermatitis 59 relapsed multiple myeloma 59 TM Aganocide 59 Edurant 59 oral antiviral 59 Completes Enrollment 59 IMA# 59 Methicillin Resistant 59 AKT inhibitor 59 hepatitis B HBV 59 HCV Hepatitis C 59 treatment naive genotype 59 Romiplostim 59 Daclizumab 59 Mycamine 59 MYLOTARG 59 Tiuxetan 59 lipoglycopeptide 59 erlotinib Tarceva ® 59 Lubiprostone 59 Silodosin 59 Vascular Disrupting Agent 59 GVAX ® 59 Ciclesonide 59 ALVESCO R 59 R bendamustine hydrochloride 59 Files IND 59 Patients Treated With 59 Macrolide 59 XOPENEX R 59 administered intramuscularly 59 MuGard TM 59 HuMax HepC TM 59 posterior uveitis 59 Alvesco ® 59 PGL# 59 Tasigna nilotinib 59 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 59 oxybutynin gel 59 Gel repository corticotropin injection 59 pemphigus vulgaris 59 Taxotere docetaxel 59 ara C 59 Kuvan sapropterin dihydrochloride 59 oxaliplatin Eloxatin 59 NAVISTAR R 59 RhuDex TM 59 Oracea ® 59 MYCAMINE 59 BENLYSTA ® 59 Ranolazine 59 Inhalation Aerosol 59 Budesonide foam crofelemer 59 pralatrexate injection folate analogue 59 molecular imaging radiopharmaceutical 59 atovaquone 59 Sustiva efavirenz 59 MKC# 59 Amgen Neulasta ® 59 Natroba 58 pouchitis 58 ANDA Filing 58 sunitinib Sutent 58 orally administered inhibitor 58 conserved antigens NP 58 Aflibercept 58 administered concomitantly 58 XL# anticancer compounds 58 recurrent metastatic 58 neutropenia dehydration dyspnea 58 PrevOnco 58 Rimantadine 58 diclofenac sodium 58 IgG1 monoclonal antibody 58 severe hypercholesterolemia 58 Immunotherapeutic 58 Oracea TM 58 Investigational Treatment 58 histamine dihydrochloride 58 aztreonam 58 sapropterin dihydrochloride Tablets 58 alkylating agent 58 liposomal amphotericin B 58 Paraplatin ® 58 opioid induced constipation OIC 58 oritavancin semi 58 MAGE A3 ASCI 58 Copegus R 58 FUSILEV enhances 58 Neulasta R 58 Chemokine Receptor 58 NASH Huntington 58 Nebulized 58 fondaparinux sodium 58 sublingual tablets 58 structure infections ABSSSI 58 Second Pivotal Phase 58 Vidaza R 58 Omacetaxine 58 Sanvar R 58 Alvesco R 58 memantine HCl 58 Gleevec imatinib mesylate 58 dextromethorphan quinidine 58 highly purified pasteurized 58 Begins Dosing 58 drug pipeline TAFA# 58 Phase III Clinical Trial 58 Nitazoxanide 58 JAK2 Inhibitor 58 tyrosine kinase inhibitor TKI 58 pneumoniae PRSP 58 GW# [003] 58 anthracyclines taxanes 58 Serostim ® 58 Regenerative Cells 58 novel orally inhaled 58 CABP 58 SinuNase ™ 58 AzaSite TM 58 biliary tract cancer 58 topical non steroidal 58 Kepivance 58 Allovectin 7 r 58 lymphoid malignancies 58 Thiovir 58 gemcitabine Gemzar 58 Hedgehog Pathway Inhibitor 58 adenosine injection 58 Ridaforolimus 58 xanthine oxidase inhibitor 58 SinuNase TM 58 Electronic Brachytherapy System 58 oral ridaforolimus 58 Therapeutic Competitors Companies 58 Durezol TM 58 Nexavar sorafenib 58 Study Evaluating 58 paclitaxel Taxol R 58 ELADUR ™ 58 QuadraSphere 58 BCG refractory carcinoma 58 Gentamicin Surgical Implant 58 Radezolid 58 Vicriviroc 58 Epivir R 58 Resistant Staphylococcus Aureus 58 FUSILEV ® 58 R roscovitine CDK cyclin 58 Initiate Phase 58 oral nucleoside analogue 58 Sprycel dasatinib 58 injectable investigational 58 Receives Orphan Drug 58 K. pneumoniae 58 Xeloda ® 58 Friedreich Ataxia FRDA 58 known teratogen substance 58 pharyngitis tonsillitis 58 reversing heparin 58 infusional 5-FU/LV 58 glycopeptide 58 Vidaza ® 58 intranasal formulation 58 candidate NGX 58 Cutaneous T 58 Cellegesic 58 Eraxis 58 recurrent herpes labialis 58 ONCASPAR 58 sunitinib Sutent ® 58 Mg Uk 58 equine osteoarthritis marketed 58 using Innocoll proprietary 58 cytomegalovirus immune globulin 58 TRANSDUR ® 58 Zenvia ™ 58 ALVESCO ® 58 Zenpep 58 Pruvel TM 58 constipation OIC 58 oral picoplatin 58 relapsing remitting MS RRMS 58 generation purine nucleoside 58 VALSTAR 58 Receives Approvable Letter 58 IAP inhibitor 58 Progressive Multifocal Leukoencephalopathy 58 Bayer Nexavar 58 carbapenem resistant 58 Initiates Phase III 58 Adjuvanted 58 ciclopirox 58 Hycamtin ® 58 DepoCyt 58 GTC recombinant human 58 lenalidomide Revlimid R 58 Haemophilus b Conjugate 58 ARIXTRA R 58 adalimumab Humira 58 idiopathic thrombocytopenic purpura ITP 58 tumors GIST 58 modified glutathione analog 58 personalized cellular immunotherapy 58 enterococcal 58 LymphoStat B TM 58 Solagé 58 Maribavir 58 markets HP Acthar 58 cisplatin gemcitabine 58 TRISENOX ® 58 leading oral taxane 58 Medoxomil 58 oncolytic virus therapies 58 DEFLUX 58 chronic immune thrombocytopenic 58 Vidaza azacitidine 58 COLAZAL R 58 Solzira TM 58 Vitrasert ® 58 BrachySil TM 58 buccal spray 58 infectious diseases autoimmune diseases 58 Investigational Oral 58 Inhalation Solution 58 Single Dose 58 occlusion PAO 58 Demonstrates Significant 58 piperacillin tazobactam 58 de novo kidney transplant 58 INVANZ 58 Navelbine R 58 5 HT3 antagonist 58 nasal powder 58 miconazole Lauriad R 58 Soriatane R 58 lucinactant 58 Tygacil 58 Spiegelmer ® 58 PrevOnco ™ 58 penicillin amoxicillin 58 BUPHENYL 58 sores onychomycosis nail 58 pharmacologically active isomer 58 Gonal f R 58 Brentuximab Vedotin SGN 58 metastatic bladder 58 phase IIb clinical 58 MGd 58 microtubule inhibitor 58 Acute Attacks 58 Presents Positive 58 Diabetic Macular Edema 58 IL# PE#QQR 58 Leukine ® 58 ergot derivatives 58 hepatorenal syndrome 58 ZADAXIN ® 58 pain palliation 58 PROVENGE ® 58 Shows Statistically Significant 58 Alfacell proprietary ribonuclease 58 Initiates Clinical 57 recurrent metastatic ovarian cancer 57 Zarnestra 57 Gleevec resistant 57 ThermoDox R 57 Rhucin ® recombinant 57 Piperacillin 57 Gets FDA Clearance 57 transfusional iron overload 57 containing granisetron 57 phenylketonuria PKU developed 57 Captisol Enabled 57 humanized interleukin 6 57 ACTIQ ® 57 Atypical Hemolytic Uremic Syndrome 57 monoclonal antibody MAb 57 developing Bicifadine serotonin 57 Cardium Therapeutics TM 57 Sebivo 57 Granted Orphan Drug 57 ELACYT 57 carbamazepine phenobarbital phenytoin rifampin 57 Intravesical 57 Ceflatonin ® 57 metastatic castrate resistant 57 Seliciclib CYC# 57 Copegus ribavirin 57 PEGylated anti 57 Polyphenon ® E 57 cromolyn sodium 57 etanercept Enbrel 57 Kamada AAT 57 PROCTOCORT R 57 everolimus tablets 57 IONSYS TM 57 Allegra Oral Suspension 57 Oropharyngeal Candidiasis 57 Drug Eluting Stent System 57 iobenguane 57 Submits Supplemental 57 Hydrochlorothiazide Tablets 57 carcinoid syndrome 57 Clevudine 57 thrombolytic agent 57 Etravirine 57 radiation sensitizer 57 Phase 1b Clinical Trial 57 Isavuconazole 57 orally inhaled 57 Submits Response 57 Anti Factor VIII 57 Begin Clinical Trials 57 trastuzumab Herceptin R 57 virus HCV 57 receptor tyrosine kinase inhibitor 57 Phase Ib II 57 REPRONEX ® menotropins 57 Severe VOD 57 severe oral mucositis 57 erlotinib Tarceva R 57 exocrine pancreatic insufficiency EPI 57 YONDELIS 57 patients coinfected 57 metastatic hormone refractory 57 Evoclin R 57 generation DACH Platinum 57 induced mucositis 57 investigational humanized monoclonal antibody 57 MyVax R 57 systemic antifungal 57 Allovectin 7 57 VivaGel ™ 57 cutaneous T cell 57 chemotherapy induced neutropenia 57 Phase IIb clinical trials 57 VIVITROL ® 57 Gleevec Glivec 57 Besivance 57 BAL# [002] 57 Vitro Activity 57 Budesonide 57 Ceflatonin R 57 headache abdominal pain 57 Advanced Renal Cell 57 Glufosfamide 57 Liposomal 57 gastrointestinal disorders ATI 57 Histoplasmosis 57 Letairis ambrisentan 57 rheumatoid arthritis RA psoriatic 57 Civacir 57 alfa 2b 57 unresectable HCC 57 acne impetigo 57 Pegasys ® 57 pan HDAC inhibitor 57 overactive bladder syndrome 57 TRANSDUR ™ 57 Augment ™ 57 TNF Tumor Necrosis Factor 57 Chronic Lymphocytic Leukemia CLL 57 vinca alkaloid 57 Torisel temsirolimus 57 aplastic anemia AA 57 EcoNail TM 57 Receives Positive Opinion 57 FDA Approvals 57 peptidic compound 57 topical ophthalmic 57 gemcitabine Gemzar ® 57 % uracil topical 57 Clolar ® 57 Hexvix ® 57 TYZEKA 57 oral candidiasis 57 investigational monoclonal antibody 57 BUPHENYL R 57 tiapamil 57 octreotide implant 57 Deferiprone 57 ribavirin USP 57 oral beclomethasone dipropionate 57 Oral Mucositis 57 ® lenalidomide 57 Ovitrelle R Serostim 57 novel synthetic PEGylated 57 Onalta TM 57 JOULFERON 57 linezolid resistant 57 IV Busulfex 57 reflux disease GERD 57 DAYTRANA TM 57 Bone Graft 57 Haemophilus 57 pancreatic NET 57 psoriasis rheumatoid arthritis 57 Drug Candidate 57 Fodosine 57 systemic juvenile idiopathic 57 Certolizumab pegol 57 Candida infection 57 Neulasta ® 57 Macroplastique ® 57 fluoroquinolone class 57 include Phenoptin TM 57 RELISTOR ® 57 Aviptadil 57 dermatophyte 57 CHEAP ONLINE PHARMACY LOW 57 Vancomycin resistant 57 Receives Marketing Authorization 57 Tumor Response 57 ATIR 57 Taiho Pharmaceutical 57 investigational pan BCR 57 Demonstrates Positive 57 HepeX B TM 57 injected subcutaneously 57 oral salmon calcitonin 57 pseudobulbar affect PBA 57 humanised monoclonal antibody 57 cepacia 57 Zemiva ™ 57 synthetic lipoglycopeptide antibiotic 57 Disease IBD 57 Nipent R 57 Veronate R 57 neuraminidase inhibitor 57 treat atopic dermatitis 57 Patient Enrollment 57 Retisert ® 57 rifamycin 57 Generx TM 57 First Patient Treated 57 Pseudomonas lung 57 use transdermal sumatriptan 57 Emollient Foam 57 hyperphenylalaninemia HPA due 57 interferon gamma 1b 57 ferumoxytol Injection 57 Pivotal Phase 57 evaluating tivozanib 57 HYVISC ® treatment 57 Tarceva TM 57 Submits NDA 57 mertansine 57 RELOVAIR ™ 57 TKB# 57 Intravenous Infusion 57 ZEVALIN ® 57 Bordetella pertussis 57 Tykerb lapatinib 57 Telik logo TELINTRA 57 Potelligent Technology 57 fentanyl buccal tablet 57 sulfonamide 57 novel VDA molecule 57 tyrosine kinase inhibitors TKIs 57 Alferon LDO 57 Fresenius Biotech 57 phase IIb trial 57 HepaGam B 57 Trial Evaluating 57 sodium thiosulfate STS 57 Urocidin TM 57 Xelox 57 levoleucovorin 57 Fondaparinux 57 CDP# 57 Oritavancin 57 metastatic gastric 57 Zysolin TM 57 oral proteasome inhibitor 57 received CE Conformite 57 G#DT 57 Darinaparsin 57 Hodgkin lymphoma HL 57 Pharmacokinetics PK 57 PERLANE 57 Dural Regeneration Matrix 57 beta 1a 57 buccal tablet 57 urethral bulking agent 57 antibody MAb 57 Streptococcus pneumoniae serotypes 57 OncoVex 57 treat lupus renal 57 Aurexis R 57 nasal calcitonin product 57 Vaprisol 57 NDA Submission 57 Sapacitabine 57 e antigen HBeAg 57 chronic HBV 57 interferon alfacon 1 57 OMNARIS HFA 56 histone deacetylase inhibitor 56 neovascular diseases 56 candidates Augment ™ 56 inflammatory autoimmune 56 Actemra tocilizumab 56 Pirfenidone 56 Zemiva TM 56 Phase Ib IIa 56 Maleate 56 Plavix clopidogrel bisulfate 56 small molecule thrombopoietin 56 Degarelix 56 investigational pharmacologically unique 56 Metronidazole 56 Phase III Pivotal 56 bone marrow reticulin deposition 56 Adjunctive Therapy 56 novel histone deacetylase 56 rhIGF-I/rhIGFBP-3 56 Solazed 56 nucleotide analog 56 Fibrillex TM 56 KL4 Surfactant 56 REVLIMID R 56 Targretin capsules 56 INTEGRILIN R 56 Apaziquone 56 ODT metoclopramide HCl PEPCID 56 Cefazolin 56 Antifungal 56 aripiprazole Abilify 56 Thrombin topical Recombinant 56 Cethromycin 56 PHX# 56 bevirimat Study 56 Telithromycin 56 vancomycin resistant 56 commercializing Loramyc ® 56 Wound Dressing 56 candidate AQ4N 56 long acting muscarinic 56 selective immunoproteasome inhibitor 56 Intravenous Human 56 Rifampicin 56 ospemifene 56 generation oxazolidinone 56 multiple myeloma MM 56 EnteroMedics proprietary neuroblocking technology 56 methicillin sensitive 56 KSP inhibitor 56 Tibotec Therapeutics division 56 Phase 1b clinical trials 56 stage IIIb IV 56 CDK cyclin dependent 56 Ixempra 56 injection USP 56 anti inflammatory NSAID 56 R bivalirudin 56 DOXIL R 56 NUEDEXTA ™ 56 Files Investigational 56 Antiviral Therapy 56 Temodar ® 56 SIMPONI TM 56 HCl capsules 56 Bronchiectasis 56 trastuzumab DM1 T DM1 56 Interferon beta 1a 56 ZALBIN 56 Intra arterial 56 balsalazide disodium 56 resistant Staphylococcus aureus MRSA 56 GEM OS2 56 Previously Treated 56 Initiate Phase II 56 FOR FURTHER INFORMATION ABOUT 56 Melphalan 56 sulfamethoxazole 56 Somatuline Depot 56 sodium benzoate prescription 56 investigational integrase inhibitor 56 Fibrin Pad 56 imatinib Gleevec ® 56 OMNARIS Nasal Spray 56 NanoTab 56 Icatibant 56 Copegus ® 56 metastatic colorectal carcinoma 56 mitogen activated ERK kinase 56 Radioimmunotherapy 56 Alpha interferons including 56 NOXAFIL 56 biologic DMARD 56 telaprevir VX 56 Amrubicin 56 Dupuytren Contracture 56 CRMD# 56 Intravitreal injections 56 Itraconazole 56 Accelerated Partial Breast Irradiation 56 unique alkylating agent 56 Prulifloxacin 56 Haemophilus influenzae Moraxella catarrhalis 56 nitrofurantoin 56 Orphan Drug designations 56 Prospective Randomized 56 Multaq dronedarone 56 Xerese 56 AERx ® 56 dexamethasone Decadron 56 recurrent glioblastoma multiforme 56 Ganciclovir 56 oxybutynin ATD TM 56 Marketing Authorisation Application 56 Iluvien ® 56 pneumocystis pneumonia PCP 56 homozygous familial hypercholesterolemia 56 AzaSite Xtra 56 Dyloject TM 56 Soriatane 56 Zirgan 56 treat refractory angina 56 Amigal TM 56 Xanafide 56 Factor VIIa 56 radezolid 56 successfully commercialize Iluvien 56 Zavesca R 56 small molecule chemotherapeutic 56 XYOTAX TM 56 ofatumumab HuMax CD# 56 sJIA 56 metastatic renal 56 refractory acute promyelocytic 56 TELINTRA R 56 AVAPRO 56 evaluating satraplatin 56 candidates Azedra 56 MRSA Clostridium difficile 56 Prostate AdenoCarcinoma Treatment 56 intracavitary 56 beta lactamase inhibitor 56 Pathway Inhibitor 56 Fluorouracil 56 nephropathic cystinosis cystinosis 56 AA amyloidosis 56 HCV RNA polymerase 56 EOquin TM 56 Stereotaxis System 56 Ofatumumab 56 Entecavir 56 Adjunctive

Back to home page